ArticleAnnals of internal medicine2024

In adults with overweight or obesity and CVD, but without diabetes, semaglutide reduced MACE at a mean 40 mo.

Efstratios Koutroumpakis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.